Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial.

Madi, A, Fisher, D, Wilson, RH et al. (9 more authors) (2012) Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial. British Journal of Cancer, 107 (7). pp. 1037-1043. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2012, Springer Nature. This article is available under the Creative Commons CC-BY-NC-SA license.
Keywords: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cetuximab; Colorectal Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Gastrointestinal Tract; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Treatment Outcome
Dates:
  • Published: 25 September 2012
  • Accepted: 7 August 2012
  • Published (online): 30 August 2012
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 10 Mar 2020 12:40
Last Modified: 10 Mar 2020 12:40
Status: Published
Publisher: Springer Nature
Identification Number: https://doi.org/10.1038/bjc.2012.384
Related URLs:

Share / Export

Statistics